Schullian, Peter
Johnston, Edward
Laimer, Gregor
Putzer, Daniel
Eberle, Gernot
Amann, Arno
Effenberger, Maria
Maglione, Manuel
Freund, Martin C.
Loizides, Alexander
Bale, Reto http://orcid.org/0000-0003-0021-5792
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 18 May 2020
Revised: 27 August 2020
Accepted: 12 October 2020
First Online: 30 October 2020
Compliance with ethical standards
:
: The scientific guarantor of this publication is Reto Bale.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors (PS) has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Of the 883 patients, 545 have been previously reported:1Schullian P, Putzer D, Laimer G, Levy E, Bale R (2020) Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study. Eur Radiol 30:950-9602Schullian P, Johnston EW, Putzer D, Eberle G, Laimer G, Bale R (2020) Safety and efficacy of stereotactic radiofrequency ablation for very large (>/=8 cm) primary and metastatic liver tumors. Sci Rep 10:16183Schullian P, Putzer D, Silva MA, Laimer G, Kolbitsch C, Bale R (2019) Stereotactic radiofrequency ablation of liver tumors in octogenarians. Front Oncol 9:9294Schullian P, Laimer G, Putzer D, Effenberger M, Bale R (2019) Stereotactic radiofrequency ablation of primary liver tumors in the caudate lobe. HPB (Oxford). 10.1016/j.hpb.2019.09.0085Schullian P, Johnston EW, Putzer D, Eberle G, Laimer G, Bale R (2019) Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study. Int J Hyperthermia 36:876-8856Bale R, Richter M, Dunser M, Levy E, Buchberger W, Schullian P (2018) Stereotactic radiofrequency ablation for breast cancer liver metastases. J Vasc Interv Radiol 29:262-2677Bale R, Schullian P, Schmuth M, Widmann G, Jaschke W, Weinlich G (2016) Stereotactic radiofrequency ablation for metastatic melanoma to the liver. Cardiovasc Intervent Radiol 39:1128-11358Widmann G, Schullian P, Haidu M, Bale R (2012) Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardiovasc Intervent Radiol 35:570-5809Bale R, Widmann G, Schullian P et al (2012) Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol 22:930-937These prior articles dealt with complications only as a part objective whereas the current study expands on this by having a much larger patient number and includes new and much more profound analysis and comparisons.
: • retrospective• observational• performed at one institution